The Torcetrapib project was terminated on December 2, 2006 due to safety findings.

A study to look at lipid levels in subjects taking the study drug, Atorvastatin alone or placebo.

For additional information please call: 1-800-718-1021

Inclusion Criteria:

• subjects with elevated cholesterol

Exclusion Criteria:

• Women who are pregnant or lactating, or planning to become pregnant.
• Intolerance to statin therapy resulting in withdrawal
• Subjects taking any drugs known to be associated with an increased risk of myositis in combination with HMG-CoA reductase inhibitors
• Subjects with any other medical condition or laboratory abnormality which could affect subject safety, preclude evaluation of response, or render unlikely that the subject would complete the study